58
https://pubmed.ncbi.nlm.nih.gov/38117036
Seladelpar, a PPAR-delta agonist, reduces interleukin-31 and bile acids in PBC patients, potentially explaining its anti-pruritic effects.
https://pubmed.ncbi.nlm.nih.gov/38117036
Seladelpar, a PPAR-delta agonist, reduces interleukin-31 and bile acids in PBC patients, potentially explaining its anti-pruritic effects.